MAP3K9
Mitogen-activated protein kinase kinase kinase 9
Also known as: M3K9_HUMAN, MEKK9, MLK1, PRKE1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P80192
- Gene
- MAP3K9
- Ensembl
- ENSG00000006432
- Chromosome
- 14
- Canonical length
- 1104 aa
- Protein class
- Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables molecular function activator activity and protein serine/threonine kinase activity. Involved in protein autophosphorylation. Predicted to be located in membrane. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1104 residues, UniProt reviewed canonical sequence.
>P80192|MAP3K9
1 MEPSRALLGC LASAAAAAPP GEDGAGAGAE EEEEEEEEAA AAVGPGELGC DAPLPYWTAV
61 FEYEAAGEDE LTLRLGDVVE VLSKDSQVSG DEGWWTGQLN QRVGIFPSNY VTPRSAFSSR
121 CQPGGEDPSC YPPIQLLEID FAELTLEEII GIGGFGKVYR AFWIGDEVAV KAARHDPDED
181 ISQTIENVRQ EAKLFAMLKH PNIIALRGVC LKEPNLCLVM EFARGGPLNR VLSGKRIPPD
241 ILVNWAVQIA RGMNYLHDEA IVPIIHRDLK SSNILILQKV ENGDLSNKIL KITDFGLARE
301 WHRTTKMSAA GTYAWMAPEV IRASMFSKGS DVWSYGVLLW ELLTGEVPFR GIDGLAVAYG
361 VAMNKLALPI PSTCPEPFAK LMEDCWNPDP HSRPSFTNIL DQLTTIEESG FFEMPKDSFH
421 CLQDNWKHEI QEMFDQLRAK EKELRTWEEE LTRAALQQKN QEELLRRREQ ELAEREIDIL
481 ERELNIIIHQ LCQEKPRVKK RKGKFRKSRL KLKDGNRISL PSDFQHKFTV QASPTMDKRK
541 SLINSRSSPP ASPTIIPRLR AIQLTPGESS KTWGRSSVVP KEEGEEEEKR APKKKGRTWG
601 PGTLGQKELA SGDEGSPQRR EKANGLSTPS ESPHFHLGLK SLVDGYKQWS SSAPNLVKGP
661 RSSPALPGFT SLMEMEDEDS EGPGSGESRL QHSPSQSYLC IPFPRGEDGD GPSSDGIHEE
721 PTPVNSATST PQLTPTNSLK RGGAHHRRCE VALLGCGAVL AATGLGFDLL EAGKCQLLPL
781 EEPEPPAREE KKRREGLFQR SSRPRRSTSP PSRKLFKKEE PMLLLGDPSA SLTLLSLSSI
841 SECNSTRSLL RSDSDEIVVY EMPVSPVEAP PLSPCTHNPL VNVRVERFKR DPNQSLTPTH
901 VTLTTPSQPS SHRRTPSDGA LKPETLLASR SPSSNGLSPS PGAGMLKTPS PSRDPGEFPR
961 LPDPNVVFPP TPRRWNTQQD STLERPKTLE FLPRPRPSAN RQRLDPWWFV SPSHARSTSP
1021 ANSSSTETPS NLDSCFASSS STVEERPGLP ALLPFQAGPL PPTERTLLDL DAEGQSQDST
1081 VPLCRAELNT HRPAPYEIQQ EFWSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAP3K9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 17 nTPM
- retina: 8.9 nTPM
- cerebral cortex: 8.3 nTPM
- esophagus: 8.2 nTPM
- testis: 6.6 nTPM
- hypothalamus: 5.3 nTPM
Single-cell type
- esophageal apical cells: 267 nCPM
- ocular epithelial cells: 90 nCPM
- retinal ganglion cells: 73 nCPM
- salivary basal cells: 62 nCPM
- alveolar cells type 1: 62 nCPM
- choroid plexus epithelial cells: 61 nCPM
Immune cell
- naive B-cell: 0.3 nTPM
- neutrophil: 0.2 nTPM
- NK-cell: 0.2 nTPM
- T-reg: 0.2 nTPM
- eosinophil: 0.1 nTPM
- memory B-cell: 0.1 nTPM
Brain region
- cerebral cortex: 79 nTPM
- cerebellum: 53 nTPM
- thalamus: 53 nTPM
- pons: 50 nTPM
- white matter: 46 nTPM
- medulla oblongata: 42 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.12
- gnomAD missense Z
- 1.27
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- positive regulation of apoptotic process
- protein autophosphorylation
- protein phosphorylation
- signal transduction
Molecular functions
- ATP binding
- JUN kinase kinase kinase activity
- MAP kinase kinase activity
- molecular function activator activity
- protein homodimerization activity
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- SH3 domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Mitogen-activated protein (MAP) kinase kinase kinase, MLK1-4
- Protein kinase, ATP binding site
- MLK1-3, SH3 domain
- SH3-like domain superfamily
- Serine/Threonine Kinases and Pseudokinases
- Protein tyrosine and serine/threonine kinase
- Variant SH3 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAP3K9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAP3K9 as an antibody target. Whether an autoantibody or antibody against MAP3K9 could matter depends on whether native MAP3K9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAP3K9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAP3K9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...